Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection

被引：15

作者：

Napoli, Niccolo ^{[5
]}

Kauffmann, Emanuele ^{[5
]}

Cacace, Concetta ^{[5
]}

Menonna, Francesca ^{[5
]}

Caramella, Davide ^{[1
]}

Cappelli, Carla ^{[1
]}

Campani, Daniela ^{[2
]}

Cacciato Insilla, Andrea ^{[2
]}

Vasile, Enrico ^{[3
]}

Vivaldi, Caterina ^{[3
]}

Fornaro, Lorenzo ^{[3
]}

Amorese, Gabriella ^{[4
]}

Vistoli, Fabio ^{[5
]}

Boggi, Ugo ^{[5
]}

机构：

[1] Univ Pisa, Azienda Osped Univ Pisana, Div Radiol, Pisa, Italy

[2] Univ Pisa, Azienda Osped Univ Pisana, Div Pathol, Pisa, Italy

[3] Univ Pisa, Azienda Osped Univ Pisana, Div Oncol, Pisa, Italy

[4] Univ Pisa, Azienda Osped Univ Pisana, Div Anesthesia & Intens Care, Pisa, Italy

[5] Univ Pisa, Azienda Osped Univ Pisana, Div Gen & Transplant Surg, Pisa, Italy

来源：

UPDATES IN SURGERY | 2021年 / 73卷 / 01期

关键词：

Locally advanced pancreatic cancer; Pancreatic cancer; Pancreatectomy; Arterial resection; Vascular resection; Prognostic score; INTERNATIONAL STUDY-GROUP; TO-LYMPHOCYTE RATIO; CLINICAL-USEFULNESS; R1; RESECTION; SURGERY; CA125; COMPLICATIONS; CHEMOTHERAPY; METAANALYSIS; METASTASIS;

D O I：

10.1007/s13304-020-00883-7

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Pancreatectomy with arterial resection is a treatment option in selected patients with locally advanced pancreatic cancer. This study aimed to identify factors predicting cancer-specific survival in this patient population. A single-Institution prospective database was used. Pre-operative prognostic factors were identified and used to develop a prognostic score. Matching with pathologic parameters was used for internal validation. In a patient population with a median Ca 19.9 level of 19.8 U/mL(IQR: 7.1-77), cancer-specific survival was predicted by: metabolic deterioration of diabetes (OR = 0.22,p = 0.0012), platelet count (OR = 1.00;p = 0.0013), serum level of Ca 15.3 (OR = 1.01,p = 0.0018) and Ca 125 (OR = 1.02,p = 0.00000137), neutrophils-to-lymphocytes ratio (OR = 1.16;p = 0.00015), lymphocytes-to-monocytes ratio (OR = 0.88;p = 0.00233), platelets-to-lymphocytes ratio (OR = 0.99;p = 0.00118), and FOLFIRINOX neoadjuvant chemotherapy (OR = 0.57;p = 0.00144). A prognostic score was developed and three risk groups were identified. Harrell's C-Index was 0.74. Median cancer-specific survival was 16.0 months (IQR: 12.3-28.2) for the high-risk group, 24.7 months (IQR: 17.6-33.4) for the intermediate-risk group, and 39.0 months (IQR: 22.7-NA) for the low-risk group (p = 0.0003). Matching the three risk groups against pathology parameters, N2 rate was 61.9, 42.1, and 23.8% (p = 0.04), median value of lymph-node ratio was 0.07 (IQR: 0.05-0.14), 0.04 (IQR:0.02-0.07), and 0.03 (IQR: 0.01-0.04) (p = 0.008), and mean value of logarithm odds of positive nodes was - 1.07 +/- 0.5, - 1.3 +/- 0.4, and - 1.4 +/- 0.4 (p = 0.03), in the high-risk, intermediate-risk, and low-risk groups, respectively. An online calculator is available at. The prognostic factors identified in this study predict cancer-specific survival in patients with locally advanced pancreatic cancer and low Ca 19.9 levels undergoing pancreatectomy with arterial resection.

引用

页码：233 / 249

页数：17

共 50 条

[31] NOVEL APPROACH FOR LOCALLY ADVANCED PANCREATIC CANCER SURGERY: ARTERIAL RESECTION AND RECONSTRUCTION FIRST, R0-PANCREATECTOMY AND VEIN RESECTION SECOND. EXPERIENCE OF 106 ARTERIAL RESECTIONS
Egorov, Viacheslav
Dzigasov, Soslan
Kim, Pavel
Kolygin, Alex
Mikhail, Viborny
Bolshakov, Grigory
GASTROENTEROLOGY, 2023, 164 (06) : S1537 - S1537
[32] Pancreatectomy With Arterial and Portal Vein Reconstruction for Locally Advanced Pancreatic Cancer - A Case Report and Literature Review
Brasoveanu, Vladislav
Romanescu, Dragos
Barbu, Ion
Balescu, Irina
Bacalbasa, Nicolae
IN VIVO, 2020, 34 (05): : 2791 - 2795
[33] Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer
Amano, Ryosuke
Kimura, Kenjiro
Nakata, Bunzo
Yamazoe, Sadaaki
Motomura, Hisashi
Yamamoto, Akira
Tanaka, Sayaka
Hirakawa, Kosei
SURGERY, 2015, 158 (01) : 191 - 200
[34] Survival Determinants after Pancreatectomy With Vascular Resection for Pancreatic Cancer
Yu, Song-Lin
Zhang, Guo-Feng
Ye, Chun
Wu, Xu-Bo
Peng, Cheng-Hong
INTERNATIONAL SURGERY, 2016, 101 (9-10) : 443 - 452
[35] Intra-arterial chemotherapy in patients with locally advanced pancreatic cancer
Jamitzky, T
Lange, OF
Scheef, W
Emde, H
Beckers, C
EUROPEAN JOURNAL OF CANCER, 1995, 31A : 889 - 889
[36] Simvastatin is Associated With Improved Survival in Patients Undergoing Resection for Pancreatic Cancer
Chang, J. I.
Jeon, C. Y.
Pandol, S. J.
Wu, B. U.
PANCREAS, 2014, 43 (08) : 1347 - 1348
[37] Sarcopenia and survival in patients undergoing pancreatic resection
Onesti, Jill K.
Wright, G. Paul
Kenning, Sarah E.
Tierney, Mark T.
Davis, Alan T.
Doherty, Michael G.
Chung, Mathew H.
PANCREATOLOGY, 2016, 16 (02) : 284 - 289
[38] Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis
Xue, Kang
Huang, Xing
Zhao, Pengcheng
Zhang, Yi
Tian, Bole
INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (12) : 4309 - 4321
[39] Arterial Resection Without Reconstruction Following Preoperative Arterial Embolization for Locally Advanced Pancreatic Head Cancer With Arterial Invasion
Yoshitomi, H.
Sakai, N.
Shimizu, H.
Ohtsuka, M.
Kato, A.
Furukawa, K.
Takayashiki, T.
Takano, S.
Kuboki, S.
Suzuki, D.
Kagawa, S.
Miyazaki, M.
PANCREAS, 2015, 44 (08) : 1428 - 1428
[40] Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and locally advanced pancreatic cancer
Rompen, Ingmar F.
Marchetti, Alessio
Levine, Jonah
Swett, Benjamin
Galimberti, Veronica
Han, Jane
Riachi, Mansour E.
Habib, Joseph R.
Imam, Rami
Kaplan, Brian
Sacks, Greg D.
Cao, Wenqing
Wolfgang, Christopher L.
Javed, Ammar A.
Hewitt, D. Brock
SURGERY, 2025, 180

← 1 2 3 4 5 →